Evolent Health, Inc. (NYSE:EVH) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET

Company Participants

Seth Frank - Vice President, Investor Relations

Seth Blackley - Chief Executive Officer

John Johnson - Chief Financial Officer

Conference Call Participants

Anne Samuel - JPMorgan

Charles Rhyee - Cowen & Co.

Sean Dodge - RBC Capital Markets

Ryan Daniels - William Blair

Sandy Draper - Guggenheim

David Larsen - BTIG

Richard Close - Canaccord Genuity

Jessica Tassan - Piper Sandler

Jailendra Singh - Truist Securities

Operator

Welcome to Evolent Health's Earnings Conference Call for the Third Quarter Ended September 30, 2022. As a reminder, this conference call is being recorded. Your host for the call today from Evolent Health are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. [Operator Instructions] The call will be archived and available later this evening and for the next week via the webcast on the company's website and the section entitled Investor Relations.

We will now hand the call to Seth Frank, Evolent's Vice President of Investor Relations. Please go ahead.

Seth Frank

Thank you, and good evening. The conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today.

Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the company's presentation available in the Investor Relations section of our website or in the company's press release issued earlier and posted to the IR section of the company's website, ir.evolenthealth.com, and the Form 8-K filed by the company with the SEC earlier today. During management's presentation and discussion, we will reference certain GAAP and non-GAAP figures and metrics that can be found in our earnings release as well as a summary presentation available on the Events section of Evolent's IR website at ir.evolenthealth.com.

And now I'll turn the call over to Evolent's CEO, Seth Blackley.

Seth Blackley

Good evening, and thank you for joining the call. We'll begin by summarizing our third quarter 2022 results, update you on the business and on Evolent's three core operating priorities. John will discuss the numbers in more detail and share our updated guidance. As always, we'll then take your questions after the prepared remarks.